Skip to main content
VRCA logo
VRCA
(NASDAQ)
Verrica Pharmaceuticals Inc.
$5.47-- (--)
Loading... - Market loading

Verrica Pharmaceuticals (VRCA) Stock Price & Financial Analysis

Verrica Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$5.21 - $5.49
52-Week High$9.82
52-Week Low$3.28
Open$5.36
Volume38.65K
Average Volume (3M)38.65K
Market Cap58.27M
Shares Outstanding10.65M
Price to Sales (P/S)1.64
Price to Book (P/B)2.36
EV/EBITDA-2.46
Revenue (TTM)35.58M
Net Income (TTM)-17.89M
EPS (TTM)$-1.68
Profit Margin-50.27%
Operating Margin-34.25%
Return on Equity (ROE)-72.29%
Debt to Equity0.07
50-Day MA$6.00
200-Day MA$5.98
52-Week Change30.53%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Verrica Pharmaceuticals

What is the current stock price for VRCA?

As of the latest trading session, VRCA stock trades at $5.47. The 52-week range is $3.28–$9.82, with a day range of $5.21–$5.49.

What is the P/E ratio for VRCA?

The P/E ratio (Price-to-Earnings) for VRCA is shown in the Key Statistics section. This valuation metric helps compare Verrica Pharmaceuticals Inc. to industry peers.

Does VRCA pay dividends?

Verrica Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for VRCA?

Analyst ratings and recommendations for VRCA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of VRCA?

Verrica Pharmaceuticals's market capitalization is $58.3M, classifying it as a micro-cap company. Verrica Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.